Classification
- Anatomical main groupSSensory organs
- Therapeutic subgroupS01Ophthalmologicals
- Pharmacological subgroupS01A
- Chemical subgroupS01AB
- Chemical substanceS01AB04Sulfacetamide
Where it is registered
Each register and historical list with its number of registrations and a few of them.
United States
FDA · 81 registrations
- Klaron10% · lotion · Bausch
- Sulfacetamide Sodium10% · lotion · Fougera Pharms
- Sulfacetamide Sodium10%, 30% · solution/drops · Alcon Pharms LTD
- Bleph-1010% · solution/drops · Allergan
Canada
Health Canada · 30 registrations
At a glance
- ATC code
- S01AB04
- ATC group
- Sensory organs
- Registers
- 5
- Historical lists
- 1
- Registrations
- 132
- With their own page
- 88
- Companies
- 49
All medicines with Sulfacetamide
Human medicines from every register that match Sulfacetamide by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
128 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Sulfacetamide | Canada | 10 % | Solution | Not marketed | Pharma Stulln INC. |
| Sulfacetamide Sodium | United States | 10%, 30% | solution/drops | Marketed | Alcon Pharms LTD |
| Sulfacetamide Sodium | United States | 10% | lotion | Marketed | Fougera Pharms |
| Sulfacetamide Sodium | United States | 10% | ointment | Not marketed | Padagis US |
| Sulfacetamide Sodium and Prednisolone Sodium PhosphateCombination | United States | 0.23% PHOSPHATE; 10% | solution/drops | Marketed | Genus |
| Sodium Sulfacetamide | United States | 10%, 15%, 30% | solution/drops | Not marketed | Sola Barnes Hind |
| Odan-Sulfacetamide | Canada | 10 % | Solution | Not marketed | Odan Laboratoriesltd |
| Prednisolone/SulfacetamideCombination | Canada | 0.5 % / W/V + 10 % / W/V | Suspension | Not marketed | Pharma Stulln INC. |
| Cetamide | United States | 10% | ointment | Not marketed | Alcon |
| Sulfacel-15 | United States | 15% | solution/drops | Not marketed | Optopics |
| Isopto Cetamide | United States | 15% | solution/drops | Not marketed | Alcon |
| Klaron | United States | 10% | lotion | Marketed | Bausch |
| Sulfair 10 | United States | 10% | ointment | Not marketed | Pharmafair |
| Sulfair 10 | United States | 10% | solution/drops | Not marketed | Pharmafair |
| Sulfair-15 | United States | 15% | solution/drops | Not marketed | Pharmafair |
| Sulf-10 | United States | 10% | solution/drops | Not marketed | Novartis |
| Sulf-15 | United States | 15% | solution/drops | Not marketed | Novartis |
| Sulfair Forte | United States | 30% | solution/drops | Not marketed | Pharmafair |
| Sulten-10 | United States | 10% | solution/drops | Not marketed | Bausch and Lomb |
| Sodium Sulamyd | United States | 10%, 30% | solution/drops | Not marketed | Schering |
| Sodium Sulamyd | United States | 10% | ointment | Not marketed | Schering |
| Ocusulf-10 | United States | 10% | solution/drops | Not marketed | Miza Pharms USA |
| Ocusulf-30 | United States | 30% | solution/drops | Not marketed | Miza Pharms USA |
| Bleph-10 | United States | 10% | solution/drops | Not marketed | Allergan |
| Bleph-10 | United States | 10% | ointment | Not marketed | Allergan |